VIVI Cap Smart transforms injectable medication protection into a connected health-data layer, enabling patients, caregivers and digital-health platforms to capture medication-use, temperature and adherence signals.

Toronto, Ontario - Newsfile Corp. - October 5, 2026 - TempraMed Technologies Ltd. (CSE: VIVI) (OTCQB: TMPTF) (FSE: 9DY) ("TempraMed" or the "Company"), a medical technology company transforming the storage, protection and management of temperature-sensitive medications, is pleased to announce that its VIVI Cap Smart™ platform now supports connectivity with Apple Health and Google Fit, advancing the Company's strategy to make injectable medication use visible within leading health and wellness ecosystems. VIVI Cap Smart™ is TempraMed's connected temperature-protection device for insulin pens, GLP-1 therapies and other injectable medications. The product combines TempraMed's validated passive thermal-shield technology with digital capabilities designed to help patients monitor medication exposure, track injections, receive reminders and share medication-use information with caregivers, healthcare professionals and remote patient management systems. Management believes this connectivity represents an important strategic milestone for TempraMed as the healthcare market shifts toward home-based care, wearable devices, AI-enabled health platforms and patient-generated health data. While today's wearable and health platforms commonly track activity, heart rate, glucose, sleep, app engagement and health records, injectable medication use remains a major missing signal. VIVI Cap Smart is designed to close this gap by capturing medication-use and temperature-integrity data from the injectable therapies patients use every day. Highlights

• Connects injectable medication use to leading health platforms: VIVI Cap Smart connectivity with Apple Health and Google Fit is designed to allow patients to include injection-related information alongside broader personal health data.
• Creates a new data layer for injectables: The platform helps capture injection activity, medication reminders, temperature exposure and adherence-related signals from insulin, GLP-1 and other injectable medication use.
• Supports home-care and remote monitoring models: VIVI Cap Smart is designed to enable better visibility for patients, family members, caregivers and healthcare professionals as more chronic therapies move from clinics into the home.
• Pen-agnostic and platform-ready: Unlike smart-pen solutions tied to a single drug manufacturer or device format, VIVI Cap Smart is designed to work across multiple pen brands and therapy categories while adding temperature protection.
• Positions TempraMed for strategic partnerships: The Company believes injectable medication data is increasingly relevant to wearable, digital-health, AI, pharma, medical-device and payer platforms seeking new clinical signals and better patient engagement.
• Supports recurring digital-health revenue: VIVI Cap Smart is built around a connected-device and subscription model, creating the potential for software-enabled revenue in addition to hardware sales.

The Missing Signal in Digital Health: Injectable Medication Use Hundreds of millions of patients worldwide now use injectable medications for diabetes, weight management, autoimmune conditions, fertility, allergies and other chronic or acute conditions¹. At the same time, wearable devices and health platforms are becoming central to how patients and healthcare providers monitor health trends, adherence and outcomes. Despite this momentum, injectable medication behavior remains largely disconnected from the digital-health ecosystem. Wearables may track vital signs and biosensor data, but they generally do not know whether a patient actually used an injectable medication, when the injection occurred, or whether the medication was exposed to damaging temperatures before use. VIVI Cap Smart was developed to address that gap. The platform is designed to provide a universal injectable-therapy layer that combines:

• Temperature protection for in-use medications;
• Automatic injection-event capture;
• Medication reminders;
• App connectivity;
• Voice dose recognition and manual dose entry;
• Real-time alerts and data analytics; and
• Integration potential for remote patient monitoring and health platforms.

"VIVI Cap Smart is about much more than protecting medication from heat and cold, it turns the injectable medication into a connected data point. For patients, that means better reminders, more confidence and better visibility. For caregivers and clinicians, it means access to information that is usually missing. For digital-health platforms, it adds one of the most important clinical signals they do not currently capture: injectable medication use," said Ron Nagar, Chief Executive Officer of TempraMed. "Apple Health, Google Fit and...